JP2021528391A5 - - Google Patents

Info

Publication number
JP2021528391A5
JP2021528391A5 JP2020569049A JP2020569049A JP2021528391A5 JP 2021528391 A5 JP2021528391 A5 JP 2021528391A5 JP 2020569049 A JP2020569049 A JP 2020569049A JP 2020569049 A JP2020569049 A JP 2020569049A JP 2021528391 A5 JP2021528391 A5 JP 2021528391A5
Authority
JP
Japan
Prior art keywords
compound
forms
compound according
formula
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020569049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528391A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/055005 external-priority patent/WO2019239387A1/en
Publication of JP2021528391A publication Critical patent/JP2021528391A/ja
Publication of JP2021528391A5 publication Critical patent/JP2021528391A5/ja
Pending legal-status Critical Current

Links

JP2020569049A 2018-06-15 2019-06-14 Jakファミリーのキナーゼの低分子阻害物質 Pending JP2021528391A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862685737P 2018-06-15 2018-06-15
US62/685,737 2018-06-15
US201962846290P 2019-05-10 2019-05-10
US62/846,290 2019-05-10
PCT/IB2019/055005 WO2019239387A1 (en) 2018-06-15 2019-06-14 Small molecule inhibitors of the jak family of kinases

Publications (2)

Publication Number Publication Date
JP2021528391A JP2021528391A (ja) 2021-10-21
JP2021528391A5 true JP2021528391A5 (cg-RX-API-DMAC7.html) 2022-04-11

Family

ID=67766195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569049A Pending JP2021528391A (ja) 2018-06-15 2019-06-14 Jakファミリーのキナーゼの低分子阻害物質

Country Status (23)

Country Link
US (3) US20200017498A1 (cg-RX-API-DMAC7.html)
EP (1) EP3807277A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021528391A (cg-RX-API-DMAC7.html)
KR (1) KR102768284B1 (cg-RX-API-DMAC7.html)
CN (1) CN112313233A (cg-RX-API-DMAC7.html)
AU (1) AU2019286641A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020024744A2 (cg-RX-API-DMAC7.html)
CA (1) CA3101438A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020003227A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020015396A2 (cg-RX-API-DMAC7.html)
CR (1) CR20200603A (cg-RX-API-DMAC7.html)
EC (1) ECSP20080817A (cg-RX-API-DMAC7.html)
IL (1) IL279314A (cg-RX-API-DMAC7.html)
JO (1) JOP20200311A1 (cg-RX-API-DMAC7.html)
MA (1) MA52900A (cg-RX-API-DMAC7.html)
MX (1) MX2020013688A (cg-RX-API-DMAC7.html)
NI (1) NI202000100A (cg-RX-API-DMAC7.html)
PE (1) PE20212113A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551984A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202011691PA (cg-RX-API-DMAC7.html)
TW (1) TW202016110A (cg-RX-API-DMAC7.html)
UY (1) UY38262A (cg-RX-API-DMAC7.html)
WO (1) WO2019239387A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US12390451B2 (en) 2021-03-11 2025-08-19 Janssen Pharmaceutica Nv Small molecule inhibitor of the JAK family of kinases
CN113292561A (zh) * 2021-05-22 2021-08-24 中国药科大学 一种二吡咯并吡啶结构的化合物、制备方法和医药用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP2005529933A (ja) 2002-05-31 2005-10-06 シェーリング コーポレイション キサンチンホスホジエステラーゼvインヒビター多形体
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
US7737279B2 (en) 2005-05-10 2010-06-15 Bristol-Myers Squibb Company 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
WO2007005462A1 (en) 2005-07-01 2007-01-11 Wyeth Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same
JP5071374B2 (ja) 2005-07-14 2012-11-14 アステラス製薬株式会社 ヘテロ環ヤヌスキナーゼ3阻害剤
CN102127078A (zh) 2005-07-14 2011-07-20 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
AU2009257602B2 (en) 2008-06-10 2015-10-08 Abbvie Inc. Novel tricyclic compounds
SI2473510T1 (sl) 2009-09-03 2014-10-30 Bristol-Myers Squibb Company Jak2 inhibitorji in njihova uporaba za zdravljenje mieloproliferativnih bolezni in raka
JP2013512282A (ja) * 2009-12-01 2013-04-11 アボット・ラボラトリーズ 新規三環式化合物
EP4782062A2 (en) 2009-12-01 2026-07-29 AbbVie Inc. Novel tricyclic compounds
CN102712640A (zh) 2010-01-12 2012-10-03 弗·哈夫曼-拉罗切有限公司 三环杂环化合物、其组合物和应用方法
CA2789186A1 (en) 2010-02-10 2011-08-18 Genon Biotechnologies Oy Dual activity kinase domains and uses thereof
WO2013007765A1 (en) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
GB201212081D0 (en) 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph
JP6248948B2 (ja) 2013-02-08 2017-12-20 日産化学工業株式会社 3環性ピロロピリジン化合物及びjak阻害剤
EP2924026A1 (en) 2014-03-28 2015-09-30 Novartis Tiergesundheit AG Aminosulfonylmethylcyclohexanes as JAK inhibitors
JP6561984B2 (ja) 2014-05-14 2019-08-21 日産化学株式会社 3環性化合物及びjak阻害剤
ES2924698T3 (es) 2015-05-28 2022-10-10 Theravance Biopharma R&D Ip Llc Proceso e intermedios para la preparación de compuestos de naftiridina como inhibidores de quinasa JAK
WO2017079639A1 (en) 2015-11-04 2017-05-11 Mayo Foundation For Medical Education And Research Methods and materials for treating autoimmune conditions
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
US20200077658A1 (en) 2016-12-16 2020-03-12 Basf Se Pesticidal Compounds
JOP20190144A1 (ar) * 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JP6793836B2 (ja) 2016-12-16 2020-12-02 イーライ リリー アンド カンパニー 変異体idh1およびidh2阻害剤としての7−フェニルエチルアミノ−4h−ピリミド[4,5−d][1,3]オキサジン−2−オン化合物
MX2019006047A (es) 2016-12-16 2019-10-02 Nestle Sa Oligosacaridos para generacion de sabor.
CN110167938B (zh) 2017-01-11 2024-06-14 阿基利昂有限公司 作为Janus激酶抑制剂的新的氨基-咪唑并吡啶衍生物及其医药用途
CR20190379A (es) 2017-01-30 2019-10-21 Astrazeneca Ab Moduladores del receptor de estrógeno
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US20200338051A1 (en) 2019-04-24 2020-10-29 Janssen Pharmaceutica Nv Non-clinical liquid formulations of pan-jak inhibitor

Similar Documents

Publication Publication Date Title
JP2019194236A5 (cg-RX-API-DMAC7.html)
JP2021518135A5 (cg-RX-API-DMAC7.html)
JP2019048894A5 (cg-RX-API-DMAC7.html)
JP2018030858A5 (cg-RX-API-DMAC7.html)
JP2021020948A5 (cg-RX-API-DMAC7.html)
JP2018168171A5 (cg-RX-API-DMAC7.html)
JP2022078315A5 (cg-RX-API-DMAC7.html)
JP2020010717A5 (cg-RX-API-DMAC7.html)
JP2021008630A5 (cg-RX-API-DMAC7.html)
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2018521020A5 (cg-RX-API-DMAC7.html)
JP2017509667A5 (cg-RX-API-DMAC7.html)
JP2018024682A5 (cg-RX-API-DMAC7.html)
JP2019142968A5 (cg-RX-API-DMAC7.html)
JP2021005080A5 (cg-RX-API-DMAC7.html)
JP2015096530A5 (cg-RX-API-DMAC7.html)
JP2014184556A5 (cg-RX-API-DMAC7.html)
JPWO2023195530A5 (cg-RX-API-DMAC7.html)
JP2018506302A5 (cg-RX-API-DMAC7.html)
JP2017518982A5 (cg-RX-API-DMAC7.html)
JP2017226652A5 (cg-RX-API-DMAC7.html)
JP2022009681A5 (cg-RX-API-DMAC7.html)
JP2025504028A5 (cg-RX-API-DMAC7.html)
JP2020531778A5 (cg-RX-API-DMAC7.html)
CN113286798A (zh) 内环硫脒酰胺-芳基酰胺类化合物及其治疗乙型肝炎的用途